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Cold sensitivity of TRPA1 is unveiled by the prolyl
hydroxylation blockade-induced sensitization
to ROS
Takahito Miyake1, Saki Nakamura1, Meng Zhao1, Kanako So1, Keisuke Inoue2, Tomohiro Numata2,3,
Nobuaki Takahashi2, Hisashi Shirakawa1, Yasuo Mori2, Takayuki Nakagawa1,4 & Shuji Kaneko1
Mammalian transient receptor potential ankyrin 1 (TRPA1) is a polymodal nociceptor that
plays an important role in pain generation, but its role as a cold nociceptor is still
controversial. Here, we propose that TRPA1 can sense noxious cold via transduction of
reactive oxygen species (ROS) signalling. We show that inhibiting hydroxylation of a proline
residue within the N-terminal ankyrin repeat of human TRPA1 by mutation or using a prolyl
hydroxylase (PHD) inhibitor potentiates the cold sensitivity of TRPA1 in the presence of
hydrogen peroxide. Inhibiting PHD in mice triggers mouse TRPA1 sensitization sufﬁciently to
sense cold-evoked ROS, which causes cold hypersensitivity. Furthermore, this phenomenon
underlies the acute cold hypersensitivity induced by the chemotherapeutic agent oxaliplatin
or its metabolite oxalate. Thus, our ﬁndings provide evidence that blocking prolyl
hydroxylation reveals TRPA1 sensitization to ROS, which enables TRPA1 to convert ROS
signalling into cold sensitivity.
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A
nimals possess diverse sensors for various latent dangers
in the environment. The sensors are mainly located in
peripheral sensory nerves, and their activation induces
electrical pulses that are delivered to the brain and interpreted as
‘pain.’ Among such sensors, transient receptor potential ankyrin 1
(TRPA1), a polymodal cation channel, has a well-known
molecular property of nociceptor and plays a pivotal role in
various types of pain generation1. This is because TRPA1 is
opened by a large number of irritants2–4 and oxidative stimuli,
such as reactive oxygen species (ROS)5,6. The reversible covalent
or oxidative modiﬁcation of cysteine or lysine residues on the
N terminus of TRPA1 is necessary for channel opening in
these situations5–8. We previously reported another mechanism
for TRPA1 activation: hypoxia inhibits prolyl hydroxylase (PHD)
activity, which relieves TRPA1 from the PHD-dependent hydro-
xylation of a proline residue located within the N-terminal
ankyrin repeat domain (ARD) and thus leads to the opening of
this channel8. More recently, we found that PHD inhibition
is involved in the hindlimb ischaemia/reperfusion-evoked
peripheral dysesthesia in mice9.
Noxious thermal stimuli are danger signals for animals. The
molecular basis governing how animals sense noxious hot stimuli
has been well investigated, with some TRP10,11 and other12
channels identiﬁed as hot-sensing nociceptors. By contrast, the
current understanding of how noxious cold stimuli are sensed
shows limited progress, although the TRPM8-mediated mecha-
nism for sensing innocuous cool stimuli is well deﬁned13,14.
TRPA1 was initially discovered to be a noxious cold-activated
channel2 and was a candidate cold nociceptor. However, the early
literature shows some disagreement with subsequent studies
about the role of TRPA1 as a cold sensor, and it is still debated
whether TRPA1 is cold-sensitive2,15–17 or not3,4,18,19. A recent
study demonstrates that rodent but not human TRPA1 is
cold-sensitive in vitro20. By contrast, a single-point mutation in
the human TRPA1 (hTRPA1) gene is related to the familial
episodic pain syndrome that is triggered by cold21, and hTRPA1
is intrinsically a cold-gated channel22.
Some chemotherapeutic agents induce peripheral neuropathy,
including cold hypersensitivity, which leads to the discontinua-
tion of the chemotherapy. The platinum-based chemotherapeutic
agent oxaliplatin (L-OHP) often causes peculiar acute cold
hypersensitivity, unlike other chemotherapeutic agents23. We
previously reported that L-OHP, but not cisplatin or paclitaxel,
elicits rapid-onset cold hypersensitivity in mice through the
enhanced responsiveness of TRPA1 (refs 24,25). Furthermore, we
found that the characteristic metabolite of L-OHP, oxalate, is
responsible for the TRPA1-dependent cold hypersensitivity24, but
the molecular details remain unidentiﬁed.
In the present study, we hypothesize that the molecular basis of
the PHD inhibition-mediated TRPA1 activation may also
underlie the L-OHP-induced cold hypersensitivity, because the
1-carboxylate and 2-oxo functional groups of oxalate are
common to a PHD cosubstrate, a-ketoglutarate, and the artiﬁcial
PHD inhibitor dimethyloxalylglycine (DMOG)26. Furthermore,
since cold stimulation evokes mitochondria-derived ROS
generation27, we explore the relationship between the cold-
dependent ROS and cold hypersensitivity. We show that the
modiﬁcation of a single proline residue on TRPA1 augments its
sensitivity to H2O2, which endows TRPA1 with cold sensitivity
via transduction of ROS signalling.
Results
Human TRPA1 exhibits cold sensitivity by a mutation of Pro394.
We explored whether relief from PHD-mediated hydroxylation of
the proline residue at position 394 (Pro394) within the N-terminal
ARD of hTRPA1 could endow hTRPA1 with cold sensitivity in
the presence of H2O2. In whole-cell recordings from HEK293
cells expressing wild-type hTRPA1 (hTRPA1-WT), cold stimu-
lation (from 26 to 16 C) did not affect whole-cell currents in the
presence of a low concentration of H2O2 (0.1 mM), which had no
effect on the current even at room temperature. By contrast, in
mutant hTRPA1 lacking a hydroxylation-susceptible Pro394
residue (hTRPA1-P394A), cold stimulation in the presence of
H2O2-evoked whole-cell currents, which were signiﬁcantly larger
than those in hTRPA1-WT (Fig. 1a–d). The signiﬁcant increase
in the whole-cell currents of hTRPA1-P394A was observed only
at 17 C, not at 20 C and 23 C (Supplementary Fig. 1). Because
Ca2þ ions regulate the activity of TRPA1 (refs 18,28), we
performed the same experiments using a Ca2þ -free bath solution
(2mM CaCl2 was replaced with 1mM EGTA). The hTRPA1-
P394A was not activated by a combined stimulation of cold and
H2O2 (Supplementary Fig. 2), suggesting that an enhanced effect
of extracellular Ca2þ ions28 was also involved. Next, to
determine whether cold directly activates hTRPA1-P394A, we
performed inside-out patch-clamp recordings (Fig. 1e–g,
Table 1). At 26 C, hTRPA1-P394A showed higher open
probability (NPO) than did hTRPA1-WT, presumably owing to
the higher basal activity of hTRPA1-P394A (ref. 8). In the
absence of H2O2, cold stimulation (from 26 to 16 C) failed to
increase the NPO of hTRPA1-WT, but signiﬁcantly increased the
NPO of hTRPA1-P394A compared with the basal level (26 C),
although it did not reach statistical signiﬁcance when compared
with the NPO of hTRPA1-WT at 16 C. By contrast, in the
presence of 0.1 mM H2O2, the NPO of hTRPA1-P394A was
signiﬁcantly higher than that of hTRPA1-WT. Furthermore,
0.1 mMH2O2 increased the NPO of only hTRPA1-P394A at 16 C,
but not at 26 C. Single-channel conductance of hTRPA1-P394A
in the presence of 0.1 mM H2O2 at 16 C was also signiﬁcantly
larger than the basal level (26 C, no H2O2). These results suggest
that hTRPA1-P394A may be directly activated by cold, but the
presence of low concentrations of agonists is important for
further activation and dilation29 of hTRPA1-P394A, which
cannot be achieved by hTRPA1-WT. This phenomenon may be
due to the destabilization of the closed state of hTRPA1-P394A,
but not hTRPA1-WT, at a low temperature, as previously
described in rodents30.
Sensitization of hTRPA1 to ROS causes cold sensitivity. We
further investigated the cold sensitivity of hTRPA1 in intact
cells using Ca2þ imaging experiments. As expected, hTRPA1-
WT-expressing cells showed little intracellular Ca2þ concentra-
tion ([Ca2þ ]i) response to cold stimulation. By contrast, when
hTRPA1-WT-expressing cells were pretreated with the PHD
inhibitor DMOG (100 mM) for 2 h, the cold-evoked [Ca2þ ]i
responses were signiﬁcantly facilitated, even in the absence of
H2O2 (Fig. 2a,c). Similarly, hTRPA1-P394A-expressing cells
showed signiﬁcantly larger cold-evoked [Ca2þ ]i responses than
hTRPA1-WT-expressing cells (Fig. 2b,c). In HEK293 cells, we
observed cold stimulation-induced H2O2 production, which was
suppressed by pretreatment of a mitochondria-targeted anti-
oxidant mitoTEMPO (10 mM; Supplementary Fig. 3), indicating
that cold-evoked ROS is presumably derived from mitochondria,
consistent with a previous report27. Thus, we examined the
effects of mitoTEMPO on the cold-evoked [Ca2þ ]i increase.
Pretreatment with mitoTEMPO (10 mM) signiﬁcantly suppressed
the cold-evoked [Ca2þ ]i increase in both DMOG-pretreated
hTRPA1-WT- and hTRPA1-P394A-expressing cells (Fig. 2a–c).
These results demonstrate that relieving hTRPA1 from prolyl
hydroxylation enables the channel to sense cold by detecting
cold-evoked ROS production.
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Because cold-evoked ROS is responsible for the pseudo-cold
sensitivity of hTRPA1, we next examined whether inhibiting
prolyl hydroxylation at room temperature solely causes the
altered response of hTRPA1 to ROS. In hTRPA1-WT-expressing
cells, the application of H2O2 (10 mM) evoked weak [Ca2þ ]i
responses. In DMOG-pretreated hTRPA1-WT-expressing cells
(Fig. 2d,e) or hTRPA1-P394A-expressing cells (Fig. 2f,g), the
[Ca2þ ]i responses to H2O2 were signiﬁcantly enhanced com-
pared with those in hTRPA1-WT-expressing cells. We further
compared the sensitivities of hTRPA1-P394A and hTRPA1-WT
with other TRPA1 agonists (Supplementary Fig. 4). The [Ca2þ ]i
response of hTRPA1-P394A evoked by allyl isothiocyanate
(AITC, 0.3 mM), a well-known TRPA1 agonist that activates
TRPA1 via modiﬁcation of cysteine residues7, similar to ROS, was
signiﬁcantly higher than that of hTRPA1-WT. However, there
was no difference in the [Ca2þ ]i responses to menthol (3 mM)
and 2-aminoethoxydiphenyl borate (3 mM), TRPA1 agonists that
activate TRPA1 via mechanisms independent of cysteine
residues7,31. These results suggest that inhibiting prolyl
hydroxylation enhances the sensitivity of hTRPA1 to a certain
type of agonist, that is, agonists that modify the N-terminal
cysteine residues of TRPA1.
PHD inhibition induces cold hypersensitivity in mice. To
determine whether the phenomena that we observed for hTRPA1
also occur with mouse TRPA1 (mTRPA1), we performed the
same experiments using mTRPA1-expressing cells (Fig. 3). In
mTRPA1-expressing cells, cold stimulation evoked [Ca2þ ]i
responses (Fig. 3a,b), which were higher than those observed in
Table 1 | Parameters of hTRPA1-WT and hTRPA1-P394A activity in the cold and/or H2O2 stimulation.
26 C 16 C
Basal H2O2 (0.1lM) Basal H2O2 (0.1lM)
hTRPA1-WT
Conductance (pS) 37.2±1.7 34.2±1.7 41.7±2.9 43.6±3.2
NPO 0.19±0.07 0.15±0.04 0.31±0.08 0.30±0.07
hTRPA1-P394A
Conductance (pS) 40.2±1.8 42.2±1.6 47.2±3.5 51.2±2.3**
NPO 0.46±0.19 0.61±0.31 0.94±0.36* 1.43±0.52***,
w
Single-channel conductance and open probability (NPO) of single-channel currents were measured in hTRPA1-WT- or hTRPA1-P394A-expressing cells at 26 or 16 C in the presence or absence of H2O2
(0.1mM) using inside-out patches at a membrane potential of  60mV as shown in Fig. 1e–g. n¼ 13–14.
*Po0.05.
**Po0.01.
***Po0.001 versus data from the same channel at 26 C in the absence of H2O2;
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Figure 1 | Hydroxylation-susceptible Pro394 in hTRPA1 is responsible for cold sensitivity in the presence of H2O2. Either hTRPA1-WT- or hTRPA1-
P394A-expressing cells were exposed to cold in the presence or absence of 0.1 mM H2O2 and analysed by whole-cell (a–d) or inside-out patch-clamp
recordings (e–g). (a–d) Schematic diagram of a whole-cell patch-clamp conﬁguration (a) along with representative whole-cell recordings from a hTRPA1-
WT- (b) and a hTRPA1-P394A-expressing cell (c), and the statistical analysis (d, n¼ 7–8). Membrane potential was 0mV. Insets in b and c are current–
voltage relationships at the time indicated by black-ﬁlled circles. ***Po0.001 versus hTRPA1-WTunder the same condition; ##Po0.01; two-way ANOVA
with Sidak’s post hoc test. (e–g) Schematic diagram of an inside-out patch-clamp conﬁguration (e) along with representative single-channel currents of
similar inside-out patches from a hTRPA1-WT- or hTRPA1-P394A-expressing cell in the presence or absence of 0.1 mM H2O2 at 26 C (upper panels) or
16 C (lower panels) (f), and a statistical analysis of the relative open probability (NPO) compared with the basal NPO in RTor cold conditions (g, n¼ 13–14).
Membrane potential was  60mV. **Po0.01 versus hTRPA1-WTunder the same condition; #Po0.05; two-way ANOVA with Sidak’s post hoc test. All data
are expressed as mean±s.e.m. A detailed analysis of the inside-out patches is shown in Table 1. RT, room temperature.
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hTRPA1-WT-expressing cells (see Fig. 2a,c). Consistent with
hTRPA1, pretreatment with DMOG (100 mM) signiﬁcantly
enhanced cold-evoked [Ca2þ ]i responses (Fig. 3a,b) and the
0.1 mM H2O2-induced NPO increase at 16 C (Fig. 3c) in
mTRPA1-expressing cells compared with those in non-treated
mTRPA1-expressing cells. Similarly, the cold-evoked [Ca2þ ]i
response was signiﬁcantly suppressed by the ROS scavenger
N-tert-butyl-a-phenylnitrone (PBN, 3mM; Fig. 3a,b). Further-
more, DMOG pretreatment signiﬁcantly enhanced the 10 mM
H2O2-evoked [Ca2þ ]i response of mTRPA1 at room temperature
(Fig. 3d).
Next, we performed cold-plate assays to determine whether our
in vitro ﬁndings ﬁt with an in vivo regulatory mechanism of
TRPA1 in mice. Compared with the vehicle-pre-administration
group, pre-administration of DMOG (400mg kg 1) signiﬁcantly
increased the cold escape behaviour. The DMOG-enhanced
cold escape behaviours were signiﬁcantly attenuated by the
TRPA1-selective antagonist HC030031 (100mg kg 1) or PBN
(100mg kg 1; Fig. 4a). These results suggest that PHD inhibition
is sufﬁcient to evoke cold hypersensitivity, which is dependent
on TRPA1 and ROS signalling. We next veriﬁed whether
ROS signalling also contributes to L-OHP-induced, rapid-onset
cold hypersensitivity in mice. Consistent with our previous
reports24,25, pre-administration of L-OHP (5mg kg 1) signi-
ﬁcantly increased the cold escape behaviour. The L-OHP-
enhanced cold escape behaviours were signiﬁcantly attenuated
by PBN (100mg kg 1; Fig. 4b). Taken together with the results of
our previous study24, our ﬁndings indicate that, similar to
DMOG-induced cold hypersensitivity, L-OHP-induced cold
hypersensitivity is dependent on TRPA1 and ROS signalling.
To determine whether PHD inhibition can enhance the sensitivity
of TRPA1 to ROS in vivo, we examined the effect of DMOG on
H2O2-evoked nocifensive behaviours in mice. Intraplantar (i.pl.)
injection of H2O2 (0.5%, 20 ml) in mice evoked nocifensive
behaviour, such as licking, ﬂicking and biting of the injected
paw. Pre-administration of DMOG (400mg kg 1) signiﬁ-
cantly increased the duration of the H2O2-evoked nocifensive
behaviours, which were signiﬁcantly attenuated by HC030031
(100mg kg 1; Fig. 4c). We next examined the effect of
L-OHP on the H2O2-evoked nocifensive behavioural response.
Because L-OHP is metabolized to oxalate and dichloro(1,2-
diaminocyclohexane)platinum(II) (Pt(DACH)Cl2), we performed
similar experiments but using L-OHP as well as the membrane-
permeable oxalate analogue dimethyl oxalate (DMO) and
Pt(DACH)Cl2. Pre-administration of L-OHP (5mg kg 1) or
DMO (1.7mg kg 1) signiﬁcantly enhanced H2O2-evoked
nocifensive behaviours, and these effects of both compounds
were signiﬁcantly suppressed by HC030031 (100mg kg 1).
However, pre-administration of Pt(DACH)Cl2 (4.8mg kg 1)
had no effect (Fig. 4d), suggesting that the enhanced TRPA1-
mediated nocifensive behaviour induced by L-OHP is mediated
through oxalate, but not its platinum metabolite.
We next performed in vitro experiments using cultured dorsal
root ganglia (DRG) neurons derived from wild-type or TRPA1-
knockout (KO) mice. In wild-type DRG neurons, applying H2O2
(100 mM) induced no or weak [Ca2þ ]i responses. When wild-
type DRG neurons were pretreated with L-OHP (100 mM) or
DMO (30 mM) for 2 h, the [Ca2þ ]i responses to H2O2 at room
temperature were signiﬁcantly augmented compared with those
of vehicle-pretreated DRG neurons. By contrast, few TRPA1-
KO-DRG neurons responded to H2O2 even following pretreat-


































































































































































d e f g
a b c
Figure 2 | Enhanced response to ROS induced by relief from prolyl hydroxylation mediates cold sensitivity of hTRPA1. DMOG-pretreated hTRPA1-WT-
or hTRPA1-P394A-expressing cells were exposed to cold (a–c) or 10mM H2O2 (d–g) and analysed using Ca2þ imaging experiments. (a–c) Representative
traces of cold-induced [Ca2þ ]i responses in hTRPA1-WT-expressing cells pretreated with or without 100mM DMOG for 2 h (a, n¼ 7–20 cells) and
hTRPA1-P394A-expressing cells (b, n¼ 11–16 cells) with or without 10mM mitoTEMPO pretreatment, and statistical analysis (c, n¼45–75 cells).
***Po0.001 versus non-treated hTRPA1-WT (white bar); #Po0.05, ##Po0.01; one-way ANOVA with Tukey’s post hoc test. (d,e) Representative traces of
10mM H2O2-evoked [Ca2þ ]i responses in hTRPA1-WT-expressing cells pretreated with vehicle (control) or 100 mM DMOG for 2 h (d, n¼47–55 cells),
and statistical analysis (e, n¼4–8). *Po0.05; unpaired t test. (f,g) Representative traces of the [Ca2þ ]i response evoked by 10mM H2O2 in hTRPA1-WT-
or hTRPA1-P394A-expressing cells (f, n¼43–46 cells), and statistical analysis (g, n¼ 5–6). *Po0.05; unpaired t test. All data are expressed as
mean±s.e.m. Ctrl, control.
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selectively enhance the sensitivity of TRPA1, but not other
ROS-sensitive channels, in DRG neurons.
L-OHP induces hTRPA1 sensitization via PHD inhibition. We
further examined the molecular basis underlying the L-OHP-
induced hTRPA1 sensitization. In hTRPA1-WT-expressing
HEK293 cells, pretreatment with L-OHP (100 mM) or DMO
(30 mM) for 2 h signiﬁcantly enhanced the [Ca2þ ]i responses to
H2O2 (10 mM), whereas pretreatment with Pt(DACH)Cl2 (30 mM)
had no effect (Supplementary Fig. 5). The L-OHP-enhanced
H2O2-evoked [Ca2þ ]i increase was not affected by co-pretreat-
ment with the antioxidants glutathione (1mM) or PBN (10mM;
Supplementary Fig. 5a), indicating that the ROS presumably
generated during L-OHP pretreatment32 was dispensable for the
induction of TRPA1 sensitization.
To determine whether the L-OHP- or DMO-induced hTRPA1
sensitization to ROS is PHD-dependent, we tested the effects of
L-OHP and DMO on the amount of hypoxia-inducible factor-1a
(HIF-1a), whose degradation is principally regulated by PHDs33.
Treatment of HEK293 cells with L-OHP (100 mM) or DMO
(30 mM) for 24 h increased the amount of HIF-1a similar to that
induced by CoCl2 (100 mM), a pan inhibitor of PHDs (Fig. 6a),
suggesting that L-OHP and DMO have the ability to inhibit
PHDs. Furthermore, pretreatment with L-OHP (100 mM) or
DMO (30 mM) for 2 h failed to further augment the H2O2-evoked
[Ca2þ ]i increase in hTRPA1-P394A-expressing cells (Fig. 6b) or
cells overexpressing a catalytically dead mutant of human PHD 2
(mutPHD2) in hTRPA1-WT-expressing cells (Fig. 6c). To
compete with the inhibitory effect of L-OHP on PHDs, we
overexpressed recombinant human PHD2 (wtPHD2) in the
hTRPA1-expressing cells. Overexpression of wtPHD2 abolished
the L-OHP-induced augmentation without affecting the basal
H2O2-evoked [Ca2þ ]i increase (Fig. 6c), which may be due to
incomplete inhibition of endogenous and exogenous PHDs by
L-OHP. These results demonstrate that L-OHP or oxalate
increases the sensitivity of hTRPA1 to ROS through inhibition
of the PHD-mediated hydroxylation of Pro394 in hTRPA1.
Discussion
In the present study, we found that relief from the PHD-mediated
hydroxylation of a proline residue in TRPA1 augments its
sensitivity to ROS and endows TRPA1 with cold sensitivity,











































































































Figure 3 | PHD inhibition augments cold-induced activation of mTRPA1
via an enhanced response to ROS. mTRPA1-expressing cells were exposed
to cold (a–c) or 10mM H2O2 (d) and analysed using Ca2þ imaging
experiments or inside-out patch-clamp recordings. (a) Representative
traces of cold-induced [Ca2þ ]i responses in mTRPA1-expressing cells
pretreated with or without DMOG (100mM) for 2 h (n¼8–19 cells) in the
presence or absence of 3mM PBN, and (b) statistical analysis (n¼ 39–96
cells). **Po0.01 versus non-treated mTRPA1 (white bar); ###Po0.001
versus DMOG-pretreated mTRPA1 (magenta bar); one-way ANOVA with
Tukey’s post hoc test. (c) Relative open probability (NPO) of mTRPA1 in
inside-out patches in the presence 0.1 mM H2O2 at 16 C from a mTRPA1-
expressing cell pretreated with or without DMOG (100mM) for 2 h.
n¼ 8–11. *Po0.05; unpaired t test. Membrane potential was 60mV.
(d) Statistical analysis of the H2O2-evoked [Ca
2þ ]i responses in mTRPA1-
expressing cells pretreated with or without DMOG (100mM) for 2 h.
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Figure 4 | Inhibiting PHDs contributes to TRPA1-mediated cold
hypersensitivity via an enhanced response to ROS. Mice were pre-
administered DMOG or L-OHP, and their cold escape behaviour in the
cold-plate test (a,b) or nocifensive behaviours evoked by intraplantar
injection (i.pl.) of H2O2 (c,d) were examined. (a,b) Effects of DMOG
(a, 400mg kg 1, i.p.) or L-OHP (b, 5mg kg 1, i.p.) pre-administration with
or without HC030031 (HC; 100mg kg 1, i.p.) or PBN (100mg kg 1, i.p.)
on cold escape behaviours. Numbers in parentheses indicate the number of
animals in each group. *Po0.05; **Po0.01; ***Po0.001; two-way ANOVA
with Sidak’s post hoc test. (c) Effects of DMOG pre-administration with or
without HC030031 on H2O2-evoked nocifensive behaviours. *Po0.05;
one-way ANOVA with Tukey’s post hoc test. (d) Effects of L-OHP, DMO
(1.7mg kg 1) or Pt(DACH)Cl2 (4.8mg kg 1) pre-administration with or
without HC030031 on H2O2-evoked nocifensive behaviours. *Po0.05
versus i.pl. H2O2- and i.p. vehicle-treated vehicle group (white bar);
#Po0.05; two-way ANOVA with Tukey’s post hoc test. All data are
expressed as mean±s.e.m.
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which is one mechanism underlying L-OHP-induced acute cold
hypersensitivity (Fig. 7). To the best of our knowledge, this is the
ﬁrst report indicating that chemical modiﬁcation allows geneti-
cally intact hTRPA1 to be activated by cold via sensing cold-
induced ROS generation.
ROS, such as superoxide anion and H2O2, are classically
accepted as toxic substances. However, recent studies revealed
that non-toxic levels of ROS have an alternative role as a
signalling molecule. Some TRP channel members contribute to
this signalling34. Among them, TRPA1 is the principal candidate
that regulates ROS signalling because it is the most redox-
sensitive TRP channel8. ROS-induced TRPA1 activation plays a
critical role in airway hypersensitivity35 and cerebral artery
dilation36. In addition, in peripheral sensory nerves, endogen-
ously generated redox molecules, such as H2O2 (ref. 37) and
nitroxyl38, are able to regulate TRPA1. These observations suggest
that TRPA1 acts as a polymodal sensor for detecting ROS
induced by multiple environmental changes. In our study,
noxious cold-induced H2O2 (presumably from mitochondria)
was determined to be the key molecule regulating TRPA1.
Whether TRPA1 is cold-sensitive remains a matter of debate.
TRPA1 was ﬁrst identiﬁed as a sensor of noxious cold (r17 C)2,
and subsequent studies showed the role of TRPA1 in noxious
cold sensation in vitro and in vivo15–17. Furthermore, a point
mutation (N855S) in the S4 transmembrane segment of TRPA1
was identiﬁed as the cause of autosomal-dominant familial
episodic pain syndrome characterized by episodes of debilitating
upper body pain that is triggered by fasting and physical stress,
including noxious cold21, suggesting that hTRPA1 may also be
associated with noxious cold sensation. However, this idea is
challenged by other studies showing that TRPA1 is not activated
directly by cold and fails to contribute to cold nociception3,4,18,19.
A recent study concludes that the cold activation of TRPA1 is
species speciﬁc: TRPA1 in mouse and rat is activated by cold, but
TRPA1 in human and rhesus monkey is cold-insensitive20.
However, hTRPA1 puriﬁed and reconstituted into lipid bilayers is
cold-sensitive both in the presence and absence of the N-terminal
ARD domain22. This study contradicts other studies indicating
that hTRPA1 is generally cold-insensitive4,18,20. Furthermore, an
electrophilic TRPA1 agonist AITC is able to activate puriﬁed
hTRPA1 lacking the N-terminal ARD domain22, whereas another
report also indicated that covalent modiﬁcation of the three
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Figure 5 | L-OHP or DMO augments the H2O2-evoked [Ca
2þ ]i increase in mouse DRG neurons. Shown are representative traces of 100mM H2O2-
induced [Ca2þ ]i responses in DRG neurons derived from wild-type (WT, a–c) or TRPA1-KO (e–g) mice pretreated with vehicle (a,e; control),
100mM L-OHP (b,f) or 30mM DMO (c,g) for 2 h. Statistical analysis of the H2O2-evoked [Ca2þ ]i increase is shown in d (WT-DRG; n¼ 5–6) and h
(TRPA1-KO-DRG; n¼4–5). *Po0.05 versus each control (Ctrl); one-way ANOVA with Tukey’s post hoc test. AITC, 100 mM; capsaicin, 0.3 mM; KCl, 50mM.
No difference was detected in the AITC-evoked [Ca2þ ]i increase among groups of WT-DRG neurons (relative DRatio versus vehicle: L-OHP, 1.02±0.06;
DMO, 1.14±0.13). All data are expressed as mean±s.e.m.

















































Figure 6 | L-OHP and DMO elicit hTRPA1 sensitization via PHD
inhibition. (a) Representative western blots of whole-cell lysates of
HEK293 cells pretreated with vehicle, 100 mM CoCl2, 100mM L-OHP or
30mM DMO for 24 h. CoCl2 (100mM) was used as a positive control. (b,c)
Statistical analysis of the H2O2-evoked [Ca
2þ ]i increase in hTRPA1-P394A-
expressing cells (b, n¼ 5–6) or hTRPA1-WT-expressing cells cotransfected
with vector, hPHD2 (wtPHD2) or mutant hPHD2 (mutPHD2) (c, n¼ 5–7)
pretreated with or without L-OHP (100mM) or DMO (30mM). *Po0.05;
unpaired t-test. All data are expressed as mean±s.e.m.
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for AITC-induced hTRPA1 activation7. These discrepancies may
be the result of experimental conditions; a puriﬁed channel
protein in a deﬁned membrane environment does not interact
with any other molecules. By contrast, a non-puriﬁed channel in a
living cell can interact with other regulatory molecules, such as
annexin A2 (ref. 39), TRPA1b (ref. 19), TRPV1 and Tmem100
(ref. 40). In the present study, although we found that mTRPA1
was intrinsically cold-sensitive compared with hTRPA1 (compare
Fig. 2 and Fig. 3), DMOG pretreatment further augmented the
cold-induced mTRPA1 activation, and this was suppressed by a
ROS scavenger both in vitro and in vivo. These results indicate
that ROS is important for the cold-evoked mTRPA1 activation
followed by PHD inhibition-induced cold hypersensitivity,
although another mechanism underlies the intrinsic cold
sensitivity of mTRPA1. However, we could not fully exclude
the possibility that the basal level of H2O2, in addition to the cold-
evoked H2O2 production, also contributes to the cold
hypersensitivity of TRPA1. Furthermore, although we consider
that the extracellular Ca2þ ion modulates TRPA1 directly, it is
possible that Ca2þ inﬂux triggers ROS production from
mitochondria41 thereby contributes to TRPA1 activation.
Nevertheless, our ﬁndings are unique in that the sensitized but
cold-insensitive hTRPA1 is actually able to sense noxious cold
with the aid of ROS.
L-OHP induces acute cold hypersensitivity in B90% of
patients during or within hours after infusion23,42. In addition
to our previous ﬁndings24,25, the present results further support
the possibility that the enhanced sensitivity of TRPA1 to ROS via
PHD inhibition underlies the cold hypersensitivity induced by
L-OHP, although we cannot ignore the contribution of TRPM8
(refs 43,44) or Nav1.6 (refs 45,46). Since DMOG, which does not
induce ROS generation, is sufﬁcient to induce ROS- and TRPA1-
dependent cold hypersensitivity in mice, oxalate, a characteristic
metabolite of L-OHP, seems responsible for the acute cold
hypersensitivity24,45–48 via PHD inhibition. The molecular
mechanism underlying hypoxia- and PHD-mediated sensi-
tization of sensory TRPA1 to cold and ROS may also underlie
the pathophysiological process of cold hypersensitivity induced
by peripheral ischaemia, such as in Buerger’s disease49 and
Raynaud syndrome50.
Recent ongoing studies mainly focused on the intrinsic
thermosensitivity of ion channels51. Our study represents a
signiﬁcant paradigm shift; TRPA1 is able to act as a noxious cold
sensor by transducing cold-induced ROS signalling into neuronal
activity, without directly sensing noxious cold. The molecular
mechanisms underpinning how noxious cold under physiological
conditions triggers neuronal excitation are still unclear, although
NaV1.8 (ref. 52) and NaV1.9 (ref. 53) have been implicated in
these processes. Although we could not clarify the molecular
mechanism how cold triggers mitochondrial ROS generation, it is
reported that mitochondrial ROS generated during cold
stimulation has a pivotal role in thermogeneration54. Thus, the
physiological importance of TRPA1-mediated cold detection via
ROS signalling warrants further investigation.
Methods
Animals. The C57BL/6J mice 6–8 weeks old were purchased from Japan SLC
(Shizuoka, Japan). The Trpa1 / mouse line (TRPA1-KO mice), obtained from
Jackson Laboratory (Bar Harbor, ME), was backcrossed to C57BL/6J mice for at
least ten generations and genotyped by genomic PCR using the following primers:
50-tcatctgggcaacaatgtcacctgct-30 and 50-tcctgcaagggtgattgcgttgtcta-30 . All mice were
housed in constant ambient temperature (24±1 C) and humidity (55%±10%)
conditions and under a 12 h light–dark cycle. The mice ate chow and drank water
ad libitum. All animal care and experimental procedures were performed in
accordance with the ethical guidelines of the Kyoto University Animal Research
Committee. The protocol was approved by the Kyoto University Animal Research
Committee (permission number: 2014–45, 2015–38).
Reagents. Oxaliplatin (L-OHP), H2O2 and AITC were purchased from Wako
Pure Chemical Industries (Osaka, Japan). HC030031 was obtained from Shanghai
Haoyuan Chemexpress (Shanghai, China). Menthol, 2-aminoethoxydiphenyl
borate, PBN, DMO, Pt(DACH)Cl2, cremophore EL, poly-L-lysine, D-mannitol,
glycerol, 2,20 ,4,40-tetrahydroxybenzophenone, magnesium turnings, hexane, DMF,
THF, iodine and ethyl acetate were purchased from Sigma-Aldrich (St Louis, MO).
The BAPTA (1,2-bis(2-aminophenoxy)ethane-N,N,N’,N’-tetraacetic acid) was
acquired from Dojindo Laboratories (Kumamoto, Japan). DMOG was purchased
from Frontier Scientiﬁc (Logan, Utah). The mitoTEMPO was obtained from Santa
Cruz (Dallas, TX). Laminin was acquired from Life Technologies (Carlsbad, CA).
N,N-diisopropylethylamine, 2-bromo-5-methoxytoluene, TBDMS-Cl and
PdCl2(dppf) CH2Cl2 complex (1:1) were purchased from Tokyo Chemical
Industry (Tokyo, Japan). Sodium acetate and bis(pinacolato)diboron was
purchased from WAKO (Osaka, Japan). Other drugs and chemicals were obtained
from Nacalai Tesuque (Kyoto, Japan).
Synthesis of PG-1. PG-1 was synthesized according to the literature55,56 with
slight modiﬁcations. The details are described as follows. NMR spectra were
collected in DMSO-d6 or CDCl3 at 23–26 C on JNM-ECZ500R (JEOL) at
Technical Support Ofﬁce, Department of Synthetic Chemistry and Biological
Chemistry, Graduate School of Engineering, Kyoto University. All chemical shifts
are reported in the standard d notation of parts per million using TMS as reference.



















Figure 7 | Consequence of PHD inhibition-triggered TRPA1-mediated cold hypersensitivity. (a) Cold triggers ROS generation, but cold is insufﬁcient to
activate TRPA1 with conserved PHD-mediated hydroxylation of a proline residue. (b) Inhibition of PHD (or mutating the proline residue to alanine)
enhances the sensitivity of TRPA1 to ROS. This enhanced sensitivity enables TRPA1 to sense cold-evoked ROS, which causes cold hypersensitivity. The
dotted arrows indicate the indirect or multiple pathway.
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with electron spray ionization (ESI) at Technical Support Ofﬁce, Department of
Synthetic Chemistry and Biological Chemistry, Graduate School of Engineering,
Kyoto University.
3,6-dihydroxyxanthone (1). 2,20 ,4,40-Tetrahydroxybenzophenone
(7.6 g, 31mmol) and sodium acetate (25 g, 305mmol) were dissolved in 175ml of
water. This mixture was reﬂuxed at 115 C for 20 h under air. This was transferred
to 0 C and 1N HCl (aq.) was added to bring the solution to around pH 4–5. The
crystal was collected by ﬁltration and vacuum dried to afford product 1 (6.8 g, 97%
yield). 1H-NMR (DMSO-d6, 500MHz): d 10.81 (2H, s), 7.98 (2H, d), 6.86
(2H, dd), 6.82 (2H, d).
3,6-Bis-(tert-butyldimethylsilanyloxy)xanthen-9-one (2). Imidazole
(1.65 g, 22.5mmol) and 1 (1.25 g, 5.5mmol) were dissolved in 7.5ml dry DMF
under N2. TBDMS-Cl (2.48 g, 16mmol) dissolved in 5ml dry DMF was added to
this mixture. After stirring at room temperature for 2 h, the mixture was diluted
withB20ml hexane/ethyl acetate (1:1). The organic layer was washed with water,
0.1% NaOH, brine and the solvent was removed by rotary evaporation to afford
product 2 (2.1 g, 82% yield). 1H-NMR (CDCl3, 500MHz): d 8.20 (2H, dd), 6.86
(2H, d), 6.84 (2H, d), 1.01 (18H, s) and 0.29 (12H, s).
9-[1-(2-Methyl-4-methoxyphenyl)]-6-hydroxy-3H-xanthen-3-one (3). Magne-
sium turnings (0.16 g, 6.6mmol) and iodine (1 pellet) were dissolved in 7.5ml
of anhydrous THF under N2. To this mixture, 2-bromo-5-methoxytoluene
(1.6 g, 8.0mmol) dissolved in 7.5ml anhydrous THF was added. This was reﬂuxed
at 60 C for 1 h. The solution was cooled to room temperature, and was added to a
mixture of 2 (1.2 g, 2.6mmol) in 15ml of anhydrous THF pre-cooled to  70 C.
This mixture was transferred to 0 C and was stirred for 10min. This mixture was
brought back to room temperature and stirred for additional 3 h under N2. 3ml of
4N HCl(aq) was added and further reﬂuxed at 60 C for 2 h. 5ml of 4N NaOH
followed by saturated NaH2PO4 was added to bring the solution to around pH 4.
The solvent was removed by rotary evaporation and the resulting red precipitate
was collected by ﬁltration. This was resuspended in methanol, reﬂuxed at 90 C for
1 h to dissolve completely and was crystalized at  30 C overnight The crystal was
collected by ﬁltration to afford product 3 (680mg, 79% yield). ESI–MS calculated
for [MHþ ] 333.1121, found 333.1116.
9-[1-(2-Methyl-4-methoxyphenyl)]-6-triﬂuoromethanesulfonate-3H-xanthen-
3-one (4). N-phenyl bis(triﬂuoromethanesulfonamide; 472mg, 1.3mmol) and
3 (400mg, 1.2mmol) were dissolved in 20ml of dry DMF. N,N-diisopropyl-
ethylamine (Hu¨nig’s base, 0.60ml, 3.5mmol) was added via syringe, and the
resulting solution was stirred at room temperature in the dark under N2 overnight.
The reaction was concentrated by rotary evaporation and diluted with B100ml
ethyl acetate. The organic layer was washed twice with 5% citric acid, twice with
water, once with brine and dried over Na2SO. The solvent was removed by rotary
evaporation. Puriﬁcation by silica gel column chromatography with hexane/ethyl
acetate (1:1) afforded product 4 as yellow–orange crystals (280mg, 50% yield).
1H-NMR (CDCl3, 500MHz): d 7.39 (1H, s), 7.18 (1H, d), 7.08 (2H, m), 7.02
(1H, d), 6.94 (2H, m), 6.59 (1H, dd), 6.43 (1H, d), 3.90 (3H, s), 2.06 (3H, s).
ESI–MS calculated for [MHþ ] 465.0614, found 465.0609.
9-[1-(2-Methyl-4-methoxyphenyl)]-6-pinacolatoboron-3H-xanthen-3-one
(Peroxy Green 1, PG-1 (5)). Bis(pinacolato)diboron (60mg, 0.24mmol) and
PdCl2(dppf) CH2Cl2 complex (1:1) (60mg, 0.073mmol) were added to a ﬂask
under Ar. A suspension of potassium acetate (128mg, 1.33mmol) and 4
(200mg, 0.44mmol) in anhydrous 1,4-dioxane (24ml) was added to this mixture.
This mixture was reﬂuxed at 100 C for 8 h under nitrogen. The reaction was
cooled to room temperature and diluted with pentane (25ml). The organic layer
was washed with brine (4 25ml), dried over Na2SO4, and the solvent was
removed by rotary evaporation. Puriﬁcation by silica gel column chromatography
with hexane/ethyl acetate (1:3) afforded product PG-1 (5) as an orange solid
(12.3mg, 6.3% yield). 1H-NMR (CDCl3, 500MHz): d 7.90 (1H, s), 7.56 (1H, d),
7.08 (2H, d), 7.02 (1H, d), 6.92 (2H, m), 6.59 (1H, dd), 6.44 (1H, d), 3.91 (3H, s),
2.04 (3H, s) and 1.36 (12H, s). 13C NMR (125.65MHz, CDCl3) d 186.2, 160.5,
158.8, 151.9, 148.8, 138.0, 131.1, 130.7, 130.5, 129.9, 127.2, 124.5, 123.1, 122.9,
122.0, 116.1, 111.6, 105.9, 84.5, 55.4, 29.7, 24.9 and 20.0. ESI–MS calculated for
[MHþ ] 443.2024, found 443.2022.
Plasmids. Mouse TRPA1 (GenBank accession No. NM177781.4) was cloned from
mouse brain, whole Marathon-Ready cDNA (BD Biosciences, Franklin Lakes, NJ)
by applying a PCR-based approach designed to contain the consensus sequence
from the translation initiation, and was subcloned into the expression vector
pCI-neo (Promega Corporation, Madison, WI) using XhoI and SalI sites. The
primer sequences used for the cloning of mouse TRPA1 are summarized in
Supplementary Table 1. As the hTRPA1 cDNA, hTRPA1-P394A mutant cDNA,
recombinant hPHD2 cDNA, and hPHD2 mutant cDNA in the pCIneo expression
vector, we used the same plasmids previously constructed8. The pEGFP-C3 was
purchased from Clontech Laboratories (Madison, WI).
Cell line cultures and cDNA transfection. HEK293 cells were cultured in DMEM
with GlutaMAX I (10566-016, Life Technologies) supplemented with 10% heat-
inactivated fetal bovine serum (Sigma) and maintained at 37 C in a humidiﬁed
incubator set at 5% CO2. HEK293 cells were cotransfected with recombinant
plasmids and pEGFP-C3 using SuperFect Transfection Reagent (Qiagen, Hilden,
Germany) or Lipofectamine 2000 (Life Technologies). Two days after transfection,
cells were placed onto coverslips coated with poly-L-lysine and used in electro-
physiological recording or ﬂuorometric imaging.
Primary cultures of mouse dorsal root ganglion neurons. Bilateral L1–L6 dorsal
root ganglions (DRGs) were collected from a freshly killed adult C57BL/6J male or
female mouse (6–8 weeks old). DRGs were incubated for 1 h at 37 C in Hank’s
balanced salt solution containing 137mM NaCl, 5.4mM KCl, 0.34mM Na2HPO4,
0.44mM KH2PO4, 5.6mM D-glucose and 2.4mM HEPES (adjusted to pH 7.4 with
NaOH), which contained 0.3% collagenase and 0.4% dispase. A Percoll (Sigma-
Aldrich) gradient was used to separate DRG neurons from myelin and nerve debris
as follows. Solutions of 30 and 60% Percoll were prepared with L15 medium.
The 30% Percoll solution was gently layered over the 60% Percoll solution, and
the cell suspension was gently layered over the Percoll gradient. After 10min of
centrifugation at 1,800g, the cells were collected from the Percoll interface,
suspended in 8ml of L15 medium, and centrifuged again for 5min at 1,800g. The
supernatant was removed, and the cell pellet was resuspended in 70 ml of DMEM
(D6046, Sigma) containing 10% heat-inactivated fetal bovine serum (Sigma),
penicillin G (100Uml 1) and streptomycin (100 mgml 1). The cells were plated
onto laminin-coated coverslips and incubated at 37 C in a humidiﬁed 5% CO2
atmosphere. After 4 h of incubation, 1.5ml of DMEM was added and the cells were
incubated again, but this time overnight at 37 C in a humidiﬁed 5% CO2
atmosphere.
Electrophysiology. Electrophysiological recordings were performed with a pipette
made from a glass capillary (outer diameter, 1.5mm) with a ﬁlament inside
(Narishige, Tokyo, Japan) pulled using a P-87 micropipette puller (Sutter, Novato,
CA). The access resistance ranged 2–5MO when the pipette was ﬁlled with the
pipette solution described below. For whole-cell patch-clamp recordings, the bath
solution contained 100mM NaCl, 2mM CaCl2 and 10mM HEPES (adjusted
to pH 7.4 with NaOH and 300mOsm with D-mannitol), and the pipette solution
contained 100mM Cs-aspartate, 5mM BAPTA, 1.4mM Ca-gluconate (30 nM free
Ca2þ ), 2mM MgSO4, 2mM MgCl2, 4mM Na2-ATP, 10mM Na5P3O10 and 10mM
HEPES (adjusted pH 7.4 with CsOH and 300mOsm with D-mannitol). In the Ca2þ -
free bath solution, CaCl2 was omitted and 1mM EGTA was added. Current–voltage
relationships were measured using voltage ramps ( 100 to þ 100mV over 100ms)
applied every 5 s. The membrane potential was set at 0mV. Access resistances were
compensated by 70%. Data were ﬁltered at 2.9 kHz. For inside-out patch-clamp
recordings, the bath solution contained 50mM Cs-aspartate, 50mM CsCl, 10mM
EGTA, 1mM CaCl2 (10 nM free Ca2þ ), 1mM MgCl2, 10mM Na5P3O10 and 10mM
HEPES (adjusted to pH 7.4 with CsOH and 300mOsm with D-mannitol), and the
pipette solution contained 100mM CsCl, 1mM MgCl2, 1mM EGTA and 10mM
HEPES (adjusted to pH 7.4 with CsOH and 300mOsm with D-mannitol). The
membrane potential was set at  60mV. Data were ﬁltered at 2.0 kHz. Experiments
were performed at room temperature unless otherwise stated. Cold stimulation
was performed with an SC-20 dual in-line solution heater/cooler and a CL-100
temperature controller (Warner Instruments, Hamden, CT). Patch-clamp recordings
were performed using an EPC-10 patch-clamp ampliﬁer (HEKA Instruments,
Lambrecht, Germany) and PATCHMASTER software (HEKA), and analysed using
IGOR Pro software (Wave Metrics, Portland, OR) and Clampﬁt software (Molecular
Devices, Sunnyvale, CA).
Measurement of intracellular Ca2þ concentration ([Ca2þ ]i). Cells on cover-
slips were loaded for 30–40min with 5 mM Fura-2 acetoxymethyl ester (Fura-2
AM; Dojindo Laboratories) in Krebs–Ringer solution containing 140mM NaCl,
5mM KCl, 1mM MgCl2, 2mM CaCl2, 10mM glucose and 10mM HEPES, which
contained 0.005% cremophore EL. Fluorescence images were captured every 5 s
using alternating excitation at 340 and 380 nm and emission at 510 nm with an
AQUACOSMOS/ORCA-AG imaging system (Hamamatsu Photonics, Shizuoka,
Japan). For pretreatment, DMOG (100 mM), L-OHP (100 mM), DMO (30 mM) or
Pt(DACH)Cl2 (30mM) was added to the culture medium 2 h before loading. In
Supplementary Fig. 5, cells were co-pretreated with glutathione (1mM) or PBN
(10mM) and L-OHP (100 mM) for 2 h. In Fig. 2a–c, mitoTEMPO (10 mM) was
preloaded with Fura-2 loading. Note that all of the drugs used for pretreatments
were washed out before Ca2þ imaging experiments. Experiments were performed
at room temperature unless otherwise stated. Cold stimulation was performed with
an SC-20 dual in-line solution heater/cooler and a CL-100 temperature controller
(Warner Instruments). The ratio of the ﬂuorescence intensity obtained by the
excitation/emission of 340 nm/510 nm (F340) to the ﬂuorescence intensity obtained
by the excitation/emission of 380 nm/510 nm (F380), namely F340 F380 1, was
calculated to quantify the intracellular Ca2þ concentration. Cells with an F340 F380 1
ratio 41.5 at baseline were excluded. Furthermore, in the experiments using cold
stimulation, cells showing abnormal changes in the F340 F380 1 ratio (that is, both
F340 and F380 were increased or decreased simultaneously) following cold stimu-
lation were also excluded. Statistical analysis of the change in the ratio, DRatio
(F340 F380 1), was performed as follows. In Figs 2c and 3b, the DRatio (F340 F380 1)
2min after cold stimulation was used. In Figs 2e,g, 3d, 5d,h and 6b,c, and
Supplementary Figs 4 and 5, the mean of the maximum DRatio (F340 F380 1) 5min
after the application of indicated TRPA1 agonist was used. AITC (100 mM) was
used to validate the expression of TRPA1.
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Fluorometric H2O2 measurement. Intracellular H2O2 levels were measured using
PG-1, a ﬂuorescent probe with high selectivity for H2O2 (refs 53,54). HEK293 cells
on 35mm dishes were loaded with PG-1 (5mM) with or without mitoTEMPO
(10 mM) for 40min. Then the cells were placed on ice for 5min. Then, the cells
were collected using a cell scraper, lysed with 100 ml of DMSO and centrifuged at
7,000g for 5min at 4 C. The supernatants (80ml) were loaded into a 96-well black
plate, with 0.8 ml of PG-1 (1mM) added. To remove background noise, cell-free
blanks (80 ml of DMSO plus 0.8 ml of PG-1) were prepared and the average intensity
of the blanks was subtracted from the samples. The PG-1 ﬂuorescence was
measured using a FLEX station (Molecular devices). Fluorescence measurements
were performed at room temperature. The ﬂuorescence intensity was obtained
using an excitation/emission of 485 nm/525 nm.
Western blotting. Immunoblotting analyses were performed on whole-cell lysates.
Cells grown in 35mm dishes were treated with L-OHP (100 mM), DMO (30mM) or
CoCl2 (100 mM) for 24 h at 37 C and then lysed in a RIPA buffer. Aliquots of lysate
were diluted with an equal volume of sample buffer containing (in mM) 100
Tris-HCl, 20% glycerol, 4% SDS, 12% 2-mercaptoethanol and 0.02% bromophenol
blue, and loaded onto a 10% SDS-polyacrylamide gel. Proteins were blotted
onto Immobilon-P PVDF transfer membranes (Millipore, Bedford, MA). The
membranes were trimmed and exposed to a blocking solution and then incubated
overnight at 4 C with a monoclonal mouse antibody against HIF-1a (1:200,
#NB100-105SS, Novus Biological, Littleton, CO) or a monoclonal mouse antibody
against b-actin (1:10,000, #A-1978, Sigma). The following day, the membranes
were brieﬂy washed and then incubated with peroxidase-conjugated goat anti-
mouse IgG (1:10,000, #115-035-003, GE Healthcare, Buckinghamshire, UK) for 1 h
at room temperature. Speciﬁc bands were detected with Immobilon Western
Chemiluminescent HRP Substrate (Millipore). Full blot image is shown in
Supplementary Fig. 6.
H2O2-evoked nocifensive behaviours. Male mice were used for measurement of
H2O2-evoked nocifensive behaviours. L-OHP, DMO, Pt(DACH)Cl2 and DMOG
were freshly dissolved in a 5% glucose solution. The HC030031 was dissolved in
saline containing 3% DMSO, and H2O2 was diluted with saline. Mice received a
single intraperitoneal (i.p.) administration of L-OHP (5mg kg 1), DMO
(1.7mg kg 1), Pt(DACH)Cl2 (4.8mg kg 1), DMOG (400mg kg 1) or vehicle
2 h before H2O2 (0.5%, 20ml) was subcutaneously injected into the left hind paw
(intraplantar). The doses of DMO and Pt(DACH)Cl2 were calculated from the
molecular weight of L-OHP. Vehicle or HC030031 (100mg kg 1) was i.p.
administered 30min before the injection of H2O2. The H2O2-evoked nocifensive
behaviours were measured as durations of consecutive licking, ﬂicking and biting
behaviours for 5min. Corresponding solvents were used for vehicle comparisons.
All behaviours were tested by investigators blinded to the groups.
Cold-plate test. Male mice were used in cold-plate test. Cold sensitivity
was assessed with a hot/cold-plate analgesiometer (Ugo Basile, Milan, Italy).
Mice received a single i.p. administration of L-OHP (5mg kg 1), DMOG
(400mg kg 1) or vehicle. After 1 h, the mice were allowed to acclimate to the
testing apparatus for 1 h, after which they were individually placed in the centre of
a cold-plate maintained at 5 C in a transparent Plexiglas cylinder. The HC030031
(100mg kg 1), PBN (100mg kg 1) or vehicle was i.p. administered 30min before
tests. Escape behaviours were observed for 60 s and graded with a score of 0, 1 or 2
as follows: 0, no response; 1, moderate effort to avoid cold, such as lifting a hind
paw or walking backwards; 2, vigorous effort to escape cold, such as jumping. The
sum of the scores recorded within a 60 s period was calculated. All behaviours were
tested by investigators blinded to the groups.
Statistical analysis. The data are presented as means±s.e.m. from n independent
experiments. Statistical signiﬁcances were calculated using GraphPad Prism 5 and 7
(GraphPad Software, La Jolla, CA). Differences between two groups were compared
using unpaired Student’s t-tests. Data from more than two groups were compared
using one-way or two-way analyses of variance (ANOVA), followed by Tukey’s
or Sidak’s multiple comparisons test or two-way ANOVA for repeated measures
followed by the Bonferroni’s post hoc test. In all cases, P valueso5% (Po0.05) were
considered statistically signiﬁcant.
Data availability. The data that support the ﬁndings of this study are available
from the corresponding author on reasonable request.
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